
Statement of Deviation(s) or Variation(s) in utilization of proceeds of initial Public Offer pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Filed with BSE ·

Statement of Deviation(s) or Variation(s) in utilization of proceeds of initial Public Offer pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
6ix hasn’t read this filing yet.
Follow Aptus Pharma into a list and get an email when it puts out news.
Follow Aptus Pharma